Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.
D000818:Animals; D000953:Antigens, Protozoan / Q000008:administration & dosage / Q000302:isolation & purification; D002455:Cell Division; D002460:Cell Line; D002999:Clone Cells; D003457:Cryptosporidiosis / Q000276:immunology; D016785:Cryptosporidium parvum / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D016056:Immunodominant Epitopes / Q000302:isolation & purification; D010641:Phenotype; D015800:Protozoan Proteins / Q000008:administration & dosage / Q000276:immunology / Q000302:isolation & purification; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology; D018417:Th1 Cells / Q000166:cytology / Q000276:immunology*
D000953:Antigens, Protozoan; D016207:Cytokines; D016056:Immunodominant Epitopes; D015800:Protozoan Proteins; D016692:Receptors, Antigen, T-Cell, gamma-delta; D011994:Recombinant Proteins